CN100571719C - The preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease - Google Patents
The preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease Download PDFInfo
- Publication number
- CN100571719C CN100571719C CNB2005100532184A CN200510053218A CN100571719C CN 100571719 C CN100571719 C CN 100571719C CN B2005100532184 A CNB2005100532184 A CN B2005100532184A CN 200510053218 A CN200510053218 A CN 200510053218A CN 100571719 C CN100571719 C CN 100571719C
- Authority
- CN
- China
- Prior art keywords
- filtrate
- injection
- preparation
- filter
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007924 injection Substances 0.000 title claims abstract description 65
- 238000002347 injection Methods 0.000 title claims abstract description 65
- 238000002360 preparation method Methods 0.000 title claims abstract description 46
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 12
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 12
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 205
- 239000000706 filtrate Substances 0.000 claims abstract description 90
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 83
- 239000012141 concentrate Substances 0.000 claims abstract description 69
- 241000628997 Flos Species 0.000 claims abstract description 60
- 229920000159 gelatin Polymers 0.000 claims abstract description 56
- 235000019322 gelatine Nutrition 0.000 claims abstract description 56
- 108010010803 Gelatin Proteins 0.000 claims abstract description 45
- 239000008273 gelatin Substances 0.000 claims abstract description 45
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 45
- 238000004321 preservation Methods 0.000 claims abstract description 41
- 239000003814 drug Substances 0.000 claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 28
- 229940079593 drug Drugs 0.000 claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 12
- 239000000796 flavoring agent Substances 0.000 claims abstract description 9
- 235000019634 flavors Nutrition 0.000 claims abstract description 9
- 239000012567 medical material Substances 0.000 claims abstract description 9
- 238000009472 formulation Methods 0.000 claims abstract description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 78
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 35
- 239000000243 solution Substances 0.000 claims description 25
- 238000004064 recycling Methods 0.000 claims description 24
- 238000012546 transfer Methods 0.000 claims description 23
- 229910052799 carbon Inorganic materials 0.000 claims description 19
- 238000003756 stirring Methods 0.000 claims description 14
- 238000009835 boiling Methods 0.000 claims description 13
- 238000012856 packing Methods 0.000 claims description 13
- 230000001105 regulatory effect Effects 0.000 claims description 12
- 239000001828 Gelatine Substances 0.000 claims description 11
- 239000003978 infusion fluid Substances 0.000 claims description 8
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 7
- 229930195725 Mannitol Natural products 0.000 claims description 7
- 239000000594 mannitol Substances 0.000 claims description 7
- 235000010355 mannitol Nutrition 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000001694 spray drying Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 238000004519 manufacturing process Methods 0.000 abstract description 10
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 10
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 208000029078 coronary artery disease Diseases 0.000 abstract description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 2
- 201000006306 Cor pulmonale Diseases 0.000 abstract description 2
- 208000004186 Pulmonary Heart Disease Diseases 0.000 abstract description 2
- 208000006011 Stroke Diseases 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- 208000010125 myocardial infarction Diseases 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 210000000115 thoracic cavity Anatomy 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 33
- 239000007788 liquid Substances 0.000 description 23
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 description 18
- 235000018553 tannin Nutrition 0.000 description 18
- 239000001648 tannin Substances 0.000 description 18
- 229920001864 tannin Polymers 0.000 description 18
- 238000001035 drying Methods 0.000 description 14
- 238000001556 precipitation Methods 0.000 description 14
- 239000002244 precipitate Substances 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000000605 extraction Methods 0.000 description 11
- 239000004615 ingredient Substances 0.000 description 11
- 239000000463 material Substances 0.000 description 11
- PAFLSMZLRSPALU-MRVPVSSYSA-N (2R)-3-(3,4-dihydroxyphenyl)lactic acid Chemical compound OC(=O)[C@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-MRVPVSSYSA-N 0.000 description 9
- PAFLSMZLRSPALU-QMMMGPOBSA-N Danshensu Natural products OC(=O)[C@@H](O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-QMMMGPOBSA-N 0.000 description 9
- 241000700159 Rattus Species 0.000 description 9
- PAFLSMZLRSPALU-UHFFFAOYSA-N Salvianic acid A Natural products OC(=O)C(O)CC1=CC=C(O)C(O)=C1 PAFLSMZLRSPALU-UHFFFAOYSA-N 0.000 description 9
- 229930003944 flavone Natural products 0.000 description 9
- 235000011949 flavones Nutrition 0.000 description 9
- 239000003960 organic solvent Substances 0.000 description 9
- 229960003371 protocatechualdehyde Drugs 0.000 description 9
- 238000000108 ultra-filtration Methods 0.000 description 9
- 210000004556 brain Anatomy 0.000 description 7
- 230000002879 macerating effect Effects 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 150000002212 flavone derivatives Chemical class 0.000 description 6
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 6
- 238000005352 clarification Methods 0.000 description 5
- 238000011835 investigation Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000000638 solvent extraction Methods 0.000 description 5
- YMGFTDKNIWPMGF-QHCPKHFHSA-N Salvianolic acid A Natural products OC(=O)[C@H](Cc1ccc(O)c(O)c1)OC(=O)C=Cc2ccc(O)c(O)c2C=Cc3ccc(O)c(O)c3 YMGFTDKNIWPMGF-QHCPKHFHSA-N 0.000 description 4
- YMGFTDKNIWPMGF-UCPJVGPRSA-N Salvianolic acid A Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C(=C(O)C(O)=CC=1)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 YMGFTDKNIWPMGF-UCPJVGPRSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000002490 cerebral effect Effects 0.000 description 4
- 238000003810 ethyl acetate extraction Methods 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229930183842 salvianolic acid Natural products 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 201000006474 Brain Ischemia Diseases 0.000 description 3
- WLYGSPLCNKYESI-RSUQVHIMSA-N Carthamin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@]1(O)C(O)=C(C(=O)\C=C\C=2C=CC(O)=CC=2)C(=O)C(\C=C\2C([C@](O)([C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(O)=C(C(=O)\C=C\C=3C=CC(O)=CC=3)C/2=O)=O)=C1O WLYGSPLCNKYESI-RSUQVHIMSA-N 0.000 description 3
- 241000208809 Carthamus Species 0.000 description 3
- 206010008120 Cerebral ischaemia Diseases 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000002146 bilateral effect Effects 0.000 description 3
- 208000006752 brain edema Diseases 0.000 description 3
- 206010008118 cerebral infarction Diseases 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 238000000247 postprecipitation Methods 0.000 description 3
- 229920001661 Chitosan Polymers 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 238000010241 blood sampling Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 208000001435 Thromboembolism Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000001772 anti-angiogenic effect Effects 0.000 description 1
- 210000000709 aorta Anatomy 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000008899 fufang danshen Substances 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- -1 phenol aldehyde Chemical class 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 244000132619 red sage Species 0.000 description 1
- 238000000518 rheometry Methods 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001732 thrombotic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of preparation method for the treatment of the vermilion injection of cardiovascular and cerebrovascular disease, said preparation is prepared by Radix Salviae Miltiorrhizae, Flos Carthami: distinguishing the flavor of two, medical materials decoct with water, collecting decoction, filter, filtrate adds gelatin, and cold preservation filters, filtrate concentrates, adds ethanol, adds water promptly; The ejection preparation of this preparation method preparation is normal injection agent, powder injection formulation or freeze-dried powder; Compared with prior art: the medicine of the present invention's preparation has blood circulation promoting and blood stasis dispelling, TONGMAI SHULUO, the effect of coronary blood flow increasing through laboratory observation; Experimental result shows the thoracic obstruction, the apoplexy that can be used for due to the blood stasis impatency, treatment of diseases such as coronary heart disease, myocardial infarction and blood stasis type pulmonary heart disease; The medicine that this method is produced is consistent with prior art production effect of drugs, but production cost is low especially, relatively is fit to the enterprise implement of China under-developed area, and its quality of production of production method of using in conjunction with the pharmaceutical formulation that provides is easy to control in addition.
Description
Technical field:
The present invention relates to a kind of preparation method for the treatment of the vermilion injection of cardiovascular and cerebrovascular disease, belong to the category of medical technical field.
Background technology:
It is 02153312.1 patent application document that the applicant once submitted to a name to be called " pharmaceutical composition of treatment cardiovascular and cerebrovascular disease and preparation method thereof ", application number to Patent Office of the People's Republic of China, and it provides a kind of preparation method for the treatment of coronary heart disease, anginal medicine and this medicine; The applicant also once submitted to a name to be called " preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease ", application number to Patent Office of the People's Republic of China is 2004100218845 patent application document, and it provides the preparation method of treatment coronary heart disease, anginal vermilion injection; But when in actual production process, reaching follow-up study, though we find that these production methods that we provide can produce the product with better curative effect, but method more complicated, need some expensive equipment, so its cost is than higher, invest also greatlyyer, in addition because complex process, its quality control is also difficult; This is relatively more difficult for some regional drug manufacturer enforcements that lack of capital; Influence patient's use.We find in deep research in addition: the less stable of the active ingredient salvianolic acid of Radix Salviae Miltiorrhizae, the effective ingredient Carthamus yellow of Flos Carthami, traditional Chinese medicine injection liquid drugs injection is owing to reasons such as the hydrolysis of effective ingredient, oxidations, cause medicinal liquid clarity and content of effective to descend easily, make the preparation stability variation; And Radix Salviae Miltiorrhizae is rich in tannin, the acid ingredient of its effective ingredient original pair tea phenol aldehyde and some band phenolic hydroxyl groups is similar to the chemical constituent of tannin again, physicochemical property is approaching, so the effective ingredient that desire to remove tannin in the injection of danshen preparation production technique, keeps Radix Salviae Miltiorrhizae is very difficult, tannin not only can cause the injection clarity poor, the more important thing is that tannin becomes insoluble tannalbin to cause the local absorption difficulty with protein bound in the body tissue, brings great side effect.
Summary of the invention:
The object of the invention is to provide a kind of preparation method for the treatment of the vermilion injection of cardiovascular and cerebrovascular disease at the problem of prior art existence, and to overcome the defective that prior art exists, the preparation method that provides is rationally feasible, constant product quality.
The present invention is achieved through the following technical solutions: said preparation is prepared into Radix Salviae Miltiorrhizae 2000~6000g, Flos Carthami 500~2500g: with two flavor medical materials difference or merging extracting in water, extracting solution filters, concentrate, refining with methods such as ethanol precipitation or clarifier precipitation, ultrafiltration, macroporous resin, organic solvent extractions again, filter, concentrate, dry, pulverize, get corresponding extract, and then make injection, powder pin, freeze-dried powder or infusion solution.
Said preparation prepares with Radix Salviae Miltiorrhizae 3000~4000g, Flos Carthami 1000~1500g: two flavor medical materials are decocted with water, merge decoction liquor, filter, concentrate, add gelatin, cold preservation filters, and concentrates, add ethanol, cold preservation is spent the night, and filters, transfer pH value, cold preservation filters, filtrate recycling ethanol adds the injection dilute with water to there not being the alcohol flavor, adds active carbon and boils and filter, the filtrate adjust pH, fine straining is made injection, powder pin, freeze-dried powder or infusion solution again.
Said preparation prepares with Radix Salviae Miltiorrhizae 3000~4000g, Flos Carthami 1000~1500g: get Flos Carthami, warm macerating merges leachate, filter the back and concentrate, transfer pH value, add the ethanol precipitate with ethanol, leave standstill, filter filtrate recycling ethanol, concentrate, transfer pH value, again through 2~4 ethanol precipitate with ethanol and filter concentrate after, drying, pulverize, get Flos Carthami extract; Get Radix Salviae Miltiorrhizae, pulverize, decocting boils, and merge extractive liquid, filters the back and concentrates, and transfers pH value, adds the ethanol precipitate with ethanol, leaves standstill, and filters, and filtrate recycling ethanol concentrates, and after organic solvent extraction or macroporous resin were refining, drying was pulverized again, Radix Salviae Miltiorrhizae extract; Flos Carthami extract is dissolved in water, and filters intercepting molecular weight 5000 following materials, after Radix Salviae Miltiorrhizae extract mixes, makes injection, powder pin, freeze-dried powder or infusion solution again.
Said preparation is with Radix Salviae Miltiorrhizae 3000~4000g, Flos Carthami 1000~1500g preparation: two flavor medical materials are decocted with water secondary, add 8~12 times of water gagings, each 0.5~1.5 hour at every turn, merge decoction liquor, filter, concentrate, the gelatin solution of adding 3~7% makes gelatine content reach 0.75~1.25% of quality percent by volume, stirs evenly, and cold preservation is spent the night, filter, concentrate, add ethanol and make and contain the alcohol amount more than 60%, cold preservation is spent the night, filter, filtrate is regulated pH value more than 6 with 8~12%NaOH, and cold preservation is spent the night, filter, filtrate recycling ethanol concentrates, and adds the injection dilute with water, add active carbon after boiling and be equivalent to 0.05~0.15% of crude drug amount, keep little and boiled 20~40 minutes, filter, filtrate is with 8~12%NaOH adjust pH 5.5~7.5, boil, standing over night, fine straining, filtrate adds the injection water; Make injection, powder pin, freeze-dried powder or infusion solution again.
The preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease of the present invention: take by weighing Radix Salviae Miltiorrhizae 3000~4000g, Flos Carthami 1000~1500g, get Flos Carthami, add 5~10 times of water gagings, warm macerating 1~5 time each 1~3 hour, merges leachate, filtering the back concentrates, transfer more than the PH5.0, add ethanol, leave standstill to containing the alcohol amount more than 50%, filter, filtrate recycling ethanol concentrates, and regulates more than the PH5.0, adding ethanol again is more than 60% to containing the alcohol amount, leave standstill, filter filtrate recycling ethanol, concentrate, drying is pulverized, and gets Flos Carthami extract; Radix Salviae Miltiorrhizae is pulverized, and 5~10 times of water gagings decoct each 1~3 hour 1~5 time, merge extractive liquid, filters the back and concentrates, and transfers more than the PH to 7.0, adding ethanol is more than 50% to containing the alcohol amount, leave standstill, filter filtrate recycling ethanol, concentrate, with transferring PH is acid, organic solvent extraction, combining extraction liquid, reclaim organic solvent, drying is pulverized, and gets Radix Salviae Miltiorrhizae extract, Flos Carthami extract is dissolved in water, amicon filters intercepting molecular weight 5000 following materials, mixes with Radix Salviae Miltiorrhizae extract, makes injection, powder pin, freeze-dried powder or infusion solution again.
Freeze-dried powder in the described preparation is preparation like this: with the 3750g Radix Salviae Miltiorrhizae, the 1250g Flos Carthami decocts with water secondary, adds 10 times of water gagings at every turn, each 1 hour, merge decoction liquor, filter, filtrate is concentrated into 5000ml, and the gelatin solution of adding 5% makes gelatine content be calculated as 1% by the quality percent by volume, stirs evenly, cold preservation is spent the night, and filters, and filtrate concentrates, add ethanol and make and contain alcohol amount more than 80%, cold preservation is spent the night, and filters, filtrate is regulated pH value more than 7 with 10%NaOH, cold preservation is spent the night, and filters filtrate recycling ethanol, concentrate, add the injection dilute with water, add active carbon after boiling and be equivalent to 0.1% of crude drug amount, keep little and boiled 30 minutes, filter, filtrate is boiled standing over night with 10%NaOH adjust pH 5.5~7.5, fine straining, filtrate add the injection water; 667g mannitol is mixed with 20% solution,, filters with the filtrate mixing, packing, lyophilization, promptly.
Powder injection formulation in the described preparation is preparation like this: with the 3750g Radix Salviae Miltiorrhizae, the 1250g Flos Carthami decocts with water secondary, adds 10 times of water gagings at every turn, each 1 hour, merge decoction liquor, filter, filtrate is concentrated into 5000ml, and the gelatin solution of adding 5% makes gelatine content be calculated as 1% by the quality percent by volume, stirs evenly, cold preservation is spent the night, and filters, and filtrate concentrates, add ethanol and make and contain alcohol amount more than 80%, cold preservation is spent the night, and filters, filtrate is regulated pH value more than 7 with 10%NaOH, and cold preservation is spent the night, and filters, filtrate recycling ethanol concentrates, and adds the injection dilute with water, add active carbon after boiling and be equivalent to 0.1% of crude drug amount, keep little and boiled 30 minutes, filter, filtrate is used 10%NaOH adjust pH 5.5~7.5, boil standing over night, fine straining, filtrate adds the injection water, spray drying, packing, promptly.
Injection in the described preparation is preparation like this: get 3750g Radix Salviae Miltiorrhizae, 1250g Flos Carthami, Flos Carthami adds 8 times of water gagings, warm macerating 3 times, each 2 hours.Merge leachate, filter the back and concentrate, transfer more than the PH to 6.5, add ethanol, leave standstill to containing the alcohol amount more than 60%, filter, reclaim ethanol, concentrate, transfer PH to 6.5, adding ethanol again is more than 70% to containing the alcohol amount, leave standstill, filter, reclaim ethanol, concentrate, get Flos Carthami extract after the drying; Radix Salviae Miltiorrhizae is pulverized, and decocts 3 times with 8 times of water gagings, and each 2 hours, merge extractive liquid, filtered the back and concentrates, and transfers more than the PH7.5, and adding ethanol is more than 60%, to leave standstill to containing the alcohol amount, filters, and reclaims ethanol, concentrates, with getting Radix Salviae Miltiorrhizae extract after the D101 resin purification drying; Get Flos Carthami extract and be dissolved in water, standing over night intercepts molecular weight 5000 following materials with the microporous filter membrane ultrafiltration after the coarse filtration; Radix Salviae Miltiorrhizae extract is dissolved in the Flos Carthami ultrafiltrate, adds 0.1% active carbon, boiled 30 minutes, filter, filtrate adds the injection water with NaOH adjust pH 5.5~7.5, sterilization, and packing, promptly.
Freeze-dried powder in the described preparation can also be like this preparation get 3750g Radix Salviae Miltiorrhizae, 1250g Flos Carthami, Flos Carthami adds 8 times of water gagings, warm macerating 3 times, each 2 hours.Merge leachate, filter the back and concentrate, transfer more than the PH to 6.5, add ethanol, leave standstill to containing the alcohol amount more than 60%, filter, reclaim ethanol, concentrate, transfer PH to 6.5, adding ethanol again is more than 70% to containing the alcohol amount, leave standstill, filter, reclaim ethanol, concentrate, get Flos Carthami extract after the drying; Radix Salviae Miltiorrhizae is pulverized, and decocts 3 times each 2 hours with 8 times of water gagings, merge extractive liquid, filters the back and concentrates, and transfers more than the PH7.5, adding ethanol is more than 60%, to leave standstill to containing the alcohol amount, filters, reclaim ethanol, concentrate, acid transfers PH less than 3.0, with ethyl acetate or extracted with diethyl ether 3 times, combining extraction liquid gets Radix Salviae Miltiorrhizae extract after the drying; Get Flos Carthami extract and be dissolved in water, standing over night, amicon filters intercepting molecular weight 5000 following materials after the coarse filtration; Radix Salviae Miltiorrhizae extract is dissolved in the Flos Carthami ultrafiltrate, adds 10~20% mannitol and 0.1% active carbon, boiled 30 minutes, filter, filtrate adds the injection water with NaOH adjust pH 5.5~7.5, lyophilizing, promptly.
Compared with prior art: the medicine of the present invention's preparation has blood circulation promoting and blood stasis dispelling, TONGMAI SHULUO, the effect of coronary blood flow increasing through the laboratory observation that the applicant carries out.Experimental result shows the thoracic obstruction, the apoplexy that can be used for due to the blood stasis impatency, treatment of diseases such as coronary heart disease, myocardial infarction and blood stasis type pulmonary heart disease; The applicant selects the injectable powder type for use, more helps the stable of labile element salvianolic acid, Carthamus yellow; The applicant finds to desire the effective ingredient removing tannin, keep Radix Salviae Miltiorrhizae under study for action in containing the ejection preparation production technology of Radix Salviae Miltiorrhizae very difficult.Can remove the part tannin by clarifier, ultrafiltration, macroporous resin, organic solvent extractionprocess; Clarifier can be gelatin, chitin, chitosan etc., and through preliminary experiment, this product closes and uses gelatin best, not obvious to the absorption of effective ingredient simultaneously except that the effect of tannin when carrying.But in using the gelatin clarifying process, its effect is subjected to influence of various factors such as gelatin dosage, settling time, clarifying temp, and wherein the dosage of gelatin is very crucial, and dosage is very few, and materials such as tannin are removed not exclusively, do not reach the clarification purpose; Dosage is excessive; the colloidal nature of gelatin solution can shield to particle; be difficult for clarification; and introduced a large amount of glutins, by a large amount of basic research, it is that 5% gelatin removes tannin that final the applicant adopts concentration; under the condition of alcohol precipitation concentration 80%; add adjusting PH with base value 8~9, can remove out the impurity that is insoluble to alcohol, also make simultaneously not and with tannin sedimentary gelatin to take place and solidify and remove out.But Radix Salviae Miltiorrhizae, when the Flos Carthami branch is carried, loss of effective components is bigger, through discovering may be owing to divide the extract composition simpler, gelatin has adsorbed a large amount of effective ingredient in the absorption tannin, by a large amount of experiments, the applicant adopts extraction, absorption method, ultrafiltration respectively after Radix Salviae Miltiorrhizae, Flos Carthami branch are carried, the good product quality, the curative effect that make are good.
In order to confirm that further the medicine that the present invention produces has reliable curative effect, the applicant has carried out a series of experiments:
Experimental example 1: pharmacological evaluation
(1) pharmaceutical composition of the present invention is to the protective effect of experimental rat cerebral ischemia:
Get healthy male Wistar rat, by body weight stratified random grouping, 10 every group: 1. sham operated rats; 2. normal saline matched group; 3. the present composition is heavy dose of organizes (the 14.4g crude drug/kg); 4. (the 7.2g crude drug/kg) of dosage group in the present composition; 5. present composition small dose group (3.6g crude drug/kg).2.~5. the organize each rat intraperitoneal injection respectively, every day 1 time, for three days on end.1hr after the last administration organizes each Mus lumbar injection 0.6% pentobarbital sodium solution 0.5mg/ml (30mg/ml) anesthesia to each, operation, and 1. the organize each Mus separates bilateral carotid, and 2.~5. the organize each Mus separates and ligation bilateral carotid.Behind the 3hr, put to death, get brain and claim that wet brain is heavy, calculate cerebral index.Roasting to constant weight in 110 ℃ of baking boxs then, claim dried brain heavy, calculate brain water content %.The results are shown in Table 1.
The result shows that behind healthy rat ligation bilateral common carotid arteries, obvious edema appears in cerebral tissue, shows as that wet brain representation work raises (P<0.01), cerebral index increases, brain water content significantly increases (P<0.01); Large, medium and small each dosage of the present composition can resist the cerebral tissue edema phenomenon that causes because of cerebral ischemia; wherein heavy dose can make wet brain representation work decline (P<0.05); dosage big or middle can make brain water content significantly descend (P<0.05), shows that the present composition has obvious protective effect to rat cerebral ischemia.
Table 1 present composition is to the influence of rat brain exponential sum brain water content (X ± SD)
Annotate: the normal saline group is compared with sham operated rats, and each dosage group is compared with the normal saline group, * P<0.05, * * P<0.01, all the other P>0.05
(2) to the thrombotic influence of rats in vitro: getting Wistar is 40 of rats, is divided into 4 groups at random, the ear vein drug administration by injection, and blank group is given normal saline 8ml/kg/ days; Matched group is given FUFANG DANSHEN ZHUSHEYE 8ml/kg/ days; Experimental group is given pharmaceutical composition 4 of the present invention, 8ml/kg/ days respectively, totally 4 days, 30min adopts fasting blood 1.8ml from ventral aorta after the last administration, at once inject in the silicon rubber loop, be installed on the extracorporeal thrombosis forming device,, remove unnecessary blood with 171pm running 15min, the weight in wet base that claims its thrombosis claims its dry weight again.The result: wet weight of thrombus and dry weight are reduced to respectively by 137.33 ± 9.12mg, the 52.43 ± 4.35mg of blank group: matched group 103.31 ± 11.12mg (P<0.01), 39.06 ± 4.16mg (p<0.01); Pharmaceutical composition group small dose group 108.88 ± 14.03mg of the present invention (P<0.01), 40.45 ± 5.16mg (P<0.01); The heavy dose of group of pharmaceutical composition of the present invention 102.68 ± 15.61mg (p<0.01), 37.10 ± 4.86mg (P<0.01).Show that pharmaceutical composition of the present invention has tangible anti-angiogenic thromboembolism effect.
(3) pharmaceutical composition of the present invention is to the rheol influence of rabbit blood
Select 8 of healthy rabbits, heart blood sampling before the administration, anticoagulant heparin, have a rest after 4 days, ear vein injected pharmaceutical composition 1.5ml/kg/ of the present invention days, totally 4 days, after the last administration 2 hours, heart blood sampling, anticoagulant heparin, blood before and after the administration is carried out blood rheology parameter respectively to be measured, the result: pharmaceutical composition of the present invention has the obvious suppression whole blood contrast viscosity, whole blood reduced viscosity, packed cell volume and ESR equation K value, all there were significant differences before and after the administration, and plasma viscosity and erythrocyte sedimentation rate are not had influence.
2, Radix Salviae Miltiorrhizae, Flos Carthami close and put forward technical study
(1) removes the tannin method relatively
Method salvianolic acid loss rate %
Gelatin method 15.68
Ultrafiltration 22.32
Macroreticular resin absorbing method 19.55
Ethyl acetate extraction method 19.04
According to experimental result, Radix Salviae Miltiorrhizae, Flos Carthami close to be carried the process using gelatin to remove the tannin method feasible.
(2) Radix Salviae Miltiorrhizae, Flos Carthami extract gelatin clarification condition are investigated
In the gelatin clarifying process, its effect is subjected to influence of various factors such as gelatin dosage, settling time, clarifying temp, and wherein the dosage of gelatin is very crucial, and dosage is very few, and materials such as tannin are removed not exclusively, do not reach the clarification purpose; Dosage is excessive, and the colloidal nature of gelatin solution can shield to particle, is difficult for clarification, and has introduced a large amount of glutins.
(1) index determines that selecting extractum yield, danshensu and protocatechualdehyde total amount, three of total flavones amounts is evaluation index, and assay method is as follows:
By 1/5 the recipe quantity material 1000g that gets it filled, extract by above-mentioned process conditions, filter, merging filtrate is concentrated into 1000ml.Get 6 parts, every part of 100ml adds 5% gelatin solution 10,15,20,25,30,40ml respectively, fully stirs, and standing over night under the room temperature filters, and filtrate adjustment volume supplies to measure to 150ml and uses.
1. extractum yield: because the Chinese medicine ingredients complexity, the extraction situation of measuring all the components fully is impossible, so with extractum is that extraction index investigation technology is method commonly used at present, can think that also extractum is the material base of preparation performance curative effect, its recovery rate height directly influences preparation process, is reasonable, effective control device so be chosen as the extraction index.
Assay method: precision is measured 25ml from the filtrate of gelatin post precipitation, according to " method is measured under an appendix XA of Chinese pharmacopoeia version in 2000 item.
2. the total amount of danshensu and protocatechualdehyde: adopt high performance liquid chromatography
3. general flavone content: adopt spectrophotography
The gelatin dosage is investigated result of the test
Annotate: 1. gelatin is made into 5% solution under 40 ℃;
2. gelatin dosage: the dosage in every 100ml extracting solution.
The result shows: along with the gelatin amount that adds increases, precipitation capacity increases thereupon, and the extractum yield reduces, and also loses the part effective ingredient when removing out tannin; But when after to a certain degree, along with the increase precipitation capacity of gelatin amount reduces on the contrary, the extractum yield increases, and loss of effective components increases.Comprehensive above data are considered production reality and production cost simultaneously, determine that the best dosage of gelatin of every 100ml extracting solution is 20ml, and 20 * 5% ÷ 100=1% are then arranged, and the amount that adds gelatin in promptly every 100ml medicinal liquid is 1g.
(3) gelatin clear liquor precipitate with ethanol condition is investigated: by preliminary experiment, this product is in the precipitate with ethanol process, and concentration of alcohol and pH value have the greatest impact to the precipitate with ethanol effect.
(1) determine to select danshensu and protocatechualdehyde total amount, two of total flavones amounts be evaluation index to index, and assay method is as follows: the 1. total amount of danshensu and protocatechualdehyde: the employing high effective liquid chromatography for measuring.2. general flavone content: adopt spectrophotometry.
(2) test arrangement and interpretation of result
1. recipe quantity 1/10 (500g) is got in the investigation of alcohol precipitation concentration, adopts the said extracted condition, the gelatin post precipitation, filter, be settled to 500ml and (be equivalent to 1g crude drug/ml), be divided into 5 parts (100ml/ parts), portion is organized in contrast, and wherein 4 parts add 95% ethanol and make and contain the alcohol amount and reach 60%, 70%, 80%, 90% respectively, stir, left standstill 24 hours, filter, filtrate is adjusted volume to 500ml, for having comparability, matched group also is diluted to 500ml, uses for measuring.
Alcohol precipitation concentration is investigated result of the test
The result shows: alcohol precipitation concentration is high more, and the precipitation of generation is many more, and danshensu and protocatechualdehyde total content and general flavone content there was no significant difference illustrate that when alcohol precipitation concentration increased, the precipitation major part of increase was an impurity, and loss of effective components is less.Consider the clarity and the stability of injection formulation, it is optimum to select alcohol precipitation concentration to reach more than 80%.
2. Basifying liquid medicine during the investigation precipitate with ethanol of pH value helps effective ingredient and is dissolved in the water, also is the key factor that influences the precipitate with ethanol effect simultaneously, so the pH value size is investigated during Basifying liquid medicine.Get the medical material (1000g) of 1/5 recipe quantity, adopt said method extraction, gelatin post precipitation, be concentrated into relative density 1.10~1.20, adding ethanol makes and contains the alcohol amount and reach 80%, cold preservation filters, and filtrate is divided into 10 parts, wherein transfer different pH value with 10%NaOH liquid for 9 parts, another part do not regulated pH value in contrast.Left standstill 24 hours, and filtered, filtrate is adjusted volume to 500ml, uses for measuring
PH value is investigated result of the test
The result shows: Basifying liquid medicine during precipitate with ethanol, can improve content of effective behind the precipitate with ethanol.When pH value was 9, danshensu and protocatechualdehyde total content and general flavone content were higher, consider active constituent content, and actual in conjunction with producing, should select pH value is 8~9 optimums.
(4) investigation of activated carbon dosage
Though Radix Salviae Miltiorrhizae, saffron aqueous solution are through gelatin precipitation, precipitate with ethanol, color is still darker, intends using activated carbon decolorizing by preliminary experiment, can effectively remove the pyrogen in the medicinal liquid simultaneously, improves the clarity of injection.But influential during activated carbon decolorizing to index components content, in the content that is selected at its index components of mensuration under the different activities charcoal dosage situation, and observe the medicinal liquid character, determine the consumption of active carbon with this.
Experimental technique is as follows: get 1/10 recipe quantity medical material 500g, extract by above-mentioned process conditions, after gelatin precipitation, precipitate with ethanol concentrated, thin up was divided into 5 parts to 500ml, portion does not add active carbon and organizes in contrast, all the other 4 parts add 0.05%, 0.1%, 0.2%, 0.3% active carbon after boiling respectively by the crude drug amount, fully stir the back and keep little boiling 30 minutes, filter, get filtrate, measure danshensu and protocatechualdehyde total amount and general flavone content.
The total amount of danshensu and protocatechualdehyde: adopt high effective liquid chromatography for measuring.General flavone content: adopt spectrophotometry.
The investigation result of the test of activated carbon dosage
According to result of the test, the medicinal liquid color shoals with the activated carbon dosage increase; Danshensu and protocatechualdehyde total amount and total flavones amount reduce with the increase of activated carbon dosage, and the amplitude that content reduces along with the increasing of activated carbon dosage increase, and integrated survey result, activated carbon dosage are 0.1%.
2, Radix Salviae Miltiorrhizae, Flos Carthami branch are carried except that the comparison of tannin method
Test 1 group: Radix Salviae Miltiorrhizae, Flos Carthami all adopt the gelatin method
Test 2 groups: Radix Salviae Miltiorrhizae, Flos Carthami all adopt ultrafiltration
Test 3 groups: Radix Salviae Miltiorrhizae, Flos Carthami all adopt the ethyl acetate extraction method
Test 4 groups: Radix Salviae Miltiorrhizae adopts ethyl acetate extraction method, Flos Carthami to adopt ultrafiltration
Test 5 groups: Radix Salviae Miltiorrhizae adopts macroporous adsorbent resin method, Flos Carthami to adopt ultrafiltration
Group salvianolic acid loss rate % Carthamus yellow loss rate %
1 21.17 22.56
2 20.29 20.47
3 19.38 27.34
4 19.04 18.50
5 19.21 18.65
According to result of the test, Radix Salviae Miltiorrhizae, Flos Carthami branch are carried except that the tannin method and are adopted ethyl acetate extraction method, ultrafiltration effect better respectively.
The specific embodiment:
Embodiments of the invention 1: with the 3750g Radix Salviae Miltiorrhizae, the 1250g flower decocts with water secondary, adds 10 times of water gagings at every turn, each 1 hour, merge decoction liquor, filter, filtrate is concentrated into 5000ml, and the gelatin solution of adding 5% makes gelatine content be calculated as 1% by the quality percent by volume, stirs evenly, cold preservation is spent the night, and filters, and filtrate concentrates, add ethanol and make and contain alcohol amount more than 80%, cold preservation is spent the night, and filters, filtrate is regulated pH value more than 7 with 10%NaOH, cold preservation is spent the night, and filters filtrate recycling ethanol, concentrate, add the injection dilute with water, add active carbon after boiling and be equivalent to 0.1% of crude drug amount, keep little and boiled 30 minutes, filter, filtrate is boiled standing over night with 10%NaOH adjust pH 5.5~7.5, fine straining, filtrate add the injection water; 667g mannitol is mixed with 20% solution,, filters with the filtrate mixing, packing, lyophilization promptly gets freeze-dried powder, intravenous drip, one time 4 bottles, 1 time on the one.
Embodiments of the invention 2: with the 3750g Radix Salviae Miltiorrhizae, the 1250g Flos Carthami decocts with water secondary, adds 10 times of water gagings at every turn, each 1 hour, merge decoction liquor, filter, filtrate is concentrated into 5000ml, and the gelatin solution of adding 5% makes gelatine content be calculated as 1% by the quality percent by volume, stirs evenly, cold preservation is spent the night, and filters, and filtrate concentrates, add ethanol and make and contain alcohol amount more than 80%, cold preservation is spent the night, and filters, filtrate is regulated pH value more than 7 with 10%NaOH, and cold preservation is spent the night, and filters, filtrate recycling ethanol concentrates, and adds the injection dilute with water, add active carbon after boiling and be equivalent to 0.1% of crude drug amount, keep little and boiled 30 minutes, filter, filtrate is used 10%NaOH adjust pH 5.5~7.5, boil standing over night, fine straining, filtrate adds the injection water, spray drying, packing promptly gets injectable powder.
Embodiments of the invention 3:
With the 3750g Radix Salviae Miltiorrhizae, the 1250g Flos Carthami decocts with water secondary, adds 10 times of water gagings at every turn, each 1 hour, merge decoction liquor, filter, filtrate is concentrated into 5000ml, and the gelatin solution of adding 5% makes gelatine content be calculated as 1% by the quality percent by volume, stirs evenly, cold preservation is spent the night, and filters, and filtrate concentrates, add ethanol and make and contain alcohol amount more than 80%, cold preservation is spent the night, and filters, filtrate is regulated pH value more than 7 with 10%NaOH, and cold preservation is spent the night, and filters, filtrate recycling ethanol concentrates, and adds the injection dilute with water, add active carbon after boiling and be equivalent to 0.1% of crude drug amount, keep little and boiled 30 minutes, filter, filtrate is used 10%NaOH adjust pH 5.5~7.5, boil standing over night, fine straining, filtrate adds the injection water, spray drying, packing promptly gets injection.
Embodiments of the invention 4: get 3750g Radix Salviae Miltiorrhizae, 1250g Flos Carthami, Flos Carthami adds 8 times of water gagings, warm macerating 3 times, each 2 hours.Merge leachate, filter the back and concentrate, transfer more than the PH to 6.5, add ethanol, leave standstill to containing the alcohol amount more than 60%, filter, reclaim ethanol, concentrate, transfer PH to 6.5, adding ethanol again is more than 70% to containing the alcohol amount, leave standstill, filter, reclaim ethanol, concentrate, get Flos Carthami extract after the drying; Radix Salviae Miltiorrhizae is pulverized, and decocts 3 times each 2 hours with 8 times of water gagings, merge extractive liquid, filters the back and concentrates, and transfers more than the PH7.5, adding ethanol is more than 60%, to leave standstill to containing the alcohol amount, filters, reclaim ethanol, concentrate, acid transfers PH less than 3.0, with ethyl acetate or extracted with diethyl ether 3 times, combining extraction liquid gets Radix Salviae Miltiorrhizae extract after the drying; Get Flos Carthami extract and be dissolved in water, standing over night, coarse filtration is after UF-1 sheet frame ultrafilter filters intercepting molecular weight 5000 following materials; Radix Salviae Miltiorrhizae extract is dissolved in the Flos Carthami ultrafiltrate, adds 10~20% mannitol and 0.1% active carbon, boiled 30 minutes, filter, filtrate adds the injection water with NaOH adjust pH 5.5~7.5, and lyophilizing promptly gets freeze-dried powder.
Embodiments of the invention 5: get Radix Salviae Miltiorrhizae 3000g, Flos Carthami 1000g decocts with water secondary, adds 8 times of water gagings at every turn, each 0.5 hour, merge decoction liquor, filter, concentrate, add 3% gelatin solution and make gelatine content reach 0.75 of quality percent by volume, stir evenly, cold preservation is spent the night, and filters, and concentrates, add ethanol and make and contain alcohol amount more than 60%, cold preservation is spent the night, and filters, filtrate is regulated pH value more than 6 with 8%NaOH, cold preservation is spent the night, and filters filtrate recycling ethanol, concentrate, add the injection dilute with water, add active carbon after boiling and be equivalent to 0.05% of crude drug amount, keep little and boiled 20 minutes, filter, filtrate is boiled standing over night with 8%NaOH adjust pH 5.5~7.5, fine straining, filtrate add the injection water; 667g mannitol is mixed with 15% solution,, filters with the filtrate mixing, packing, lyophilization promptly gets freeze-dried powder.
Embodiments of the invention 6: get Radix Salviae Miltiorrhizae 4000g, Flos Carthami 1500g decocts with water secondary, adds 12 times of water gagings at every turn, each 1.5 hours, merge decoction liquor, filter, concentrate, add 7% gelatin solution and make gelatine content reach 1.25% of quality percent by volume, stir evenly, cold preservation is spent the night, and filters, and concentrates, add ethanol and make and contain alcohol amount more than 90%, cold preservation is spent the night, and filters, filtrate is regulated more than the pH value to 8.5 with 8~12%NaOH, cold preservation is spent the night, and filters filtrate recycling ethanol, concentrate, add the injection dilute with water, add active carbon after boiling and be equivalent to 0.15% of crude drug amount, keep little and boiled 40 minutes, filter, filtrate is boiled standing over night with 12%NaOH adjust pH 5.5~7.5, fine straining, filtrate add the injection water; 667g mannitol is mixed with 15% solution,, filters with the filtrate mixing, packing, lyophilization promptly gets freeze-dried powder.
Embodiments of the invention 7: Radix Salviae Miltiorrhizae 3000g, Flos Carthami 1000g, get Flos Carthami, add 5 times of water gagings, warm macerating 1 hour, merge leachate, filter the back and concentrate, transfer more than the PH5.0, add ethanol to containing the alcohol amount more than 50%, leave standstill, filter, filtrate recycling ethanol concentrates, regulate more than the PH5.0, adding ethanol again is more than 60%, to leave standstill to containing the alcohol amount, filter, filtrate recycling ethanol concentrates, drying is pulverized, and gets Flos Carthami extract; Radix Salviae Miltiorrhizae is pulverized, and 5 times of water gagings decocted 1 hour, and merge extractive liquid, filters the back and concentrates, transfer more than the PH7.0, add ethanol, leave standstill, filter to containing the alcohol amount more than 50%, filtrate recycling ethanol concentrates, and is acid with transferring PH, organic solvent extraction, combining extraction liquid reclaims organic solvent, and drying is pulverized, get Radix Salviae Miltiorrhizae extract, Flos Carthami extract is dissolved in water, and filters intercepting molecular weight 5000 following materials with existing amicon, mixes with Radix Salviae Miltiorrhizae extract, add the injection water, sterilization, packing promptly gets infusion solution.
Embodiments of the invention 8: Radix Salviae Miltiorrhizae 4000g, Flos Carthami 1500g, get Flos Carthami, add 10 times of water gagings, warm macerating 5 times, each 3 hours, merge leachate, filter the back and concentrate, transfer more than the PH8.0, adding ethanol is more than 80%, to leave standstill to containing the alcohol amount, filters filtrate recycling ethanol, concentrate, regulate more than the PH8.0, adding ethanol again is more than 90%, to leave standstill to containing the alcohol amount, filter, filtrate recycling ethanol concentrates, drying is pulverized, and gets Flos Carthami extract; Radix Salviae Miltiorrhizae is pulverized, and 10 times of water gagings decoct each 3 hours 5 times, merge extractive liquid, filters the back and concentrates, and transfers more than the PH to 8.5, adding ethanol is more than 80%, to leave standstill to containing the alcohol amount, filters, filtrate recycling ethanol concentrates, and is acid with transferring PH, organic solvent extraction, combining extraction liquid reclaims organic solvent, dry, pulverize, get Radix Salviae Miltiorrhizae extract, Flos Carthami extract is dissolved in water, filter intercepting molecular weight 5000 following materials through UF-1 sheet frame ultrafilter, mix with Radix Salviae Miltiorrhizae extract, add the injection water, sterilization, packing promptly gets injection.
Embodiments of the invention 9: get Radix Salviae Miltiorrhizae 2000g, Flos Carthami 500g, add 8 times of water gagings, decoct 3 times, each 2 hours, decocting liquid filtered, and concentrated, and the chitosan precipitation concentrates, and drying is pulverized, and adds the injection water, sterilization, and packing promptly gets injection.
Embodiments of the invention 10: Radix Salviae Miltiorrhizae 6000g, Flos Carthami 2500g, two flavor medical materials are added 10 times of water gagings respectively, decoct 3 times, each 2 hours, decoction liquor filtered, and concentrated, and crossed the macropore resin purification, and spray drying promptly gets injectable powder.
Claims (4)
1, a kind of preparation method for the treatment of the vermilion injection of cardiovascular and cerebrovascular disease is characterized in that: said preparation prepares with Radix Salviae Miltiorrhizae 3000~4000g, Flos Carthami 1000~1500g: two flavor medical materials are decocted with water, merge decoction liquor, filter, concentrate, add gelatin, cold preservation, filter, concentrate, add ethanol, cold preservation is spent the night, filter, transfer pH value, cold preservation filters, filtrate recycling ethanol is to there not being the alcohol flavor, add the injection dilute with water, add active carbon and boil and filter the filtrate adjust pH, fine straining is made injection, powder pin, freeze-dried powder or infusion solution again.
2, preparation method according to the vermilion injection of the described treatment cardiovascular and cerebrovascular disease of claim 1 is characterized in that: said preparation is with Radix Salviae Miltiorrhizae 3000~4000g, Flos Carthami 1000~1500g preparation: two flavor medical materials are decocted with water secondary, add 8~12 times of water gagings at every turn, each 0.5~1.5 hour, merge decoction liquor, filter, concentrate, the gelatin solution of adding 3~7% makes gelatine content reach 0.75~1.25% of quality percent by volume, stir evenly, cold preservation is spent the night, and filters, concentrate, add ethanol and make and contain alcohol amount more than 60%, cold preservation is spent the night, and filters, filtrate is regulated pH value more than 6 with 8~12%NaOH, cold preservation is spent the night, and filters filtrate recycling ethanol, concentrate, add the injection dilute with water, add active carbon after boiling and be equivalent to 0.05~0.15% of crude drug amount, keep little and boiled 20~40 minutes, filter, filtrate is boiled with 8~12%NaOH adjust pH 5.5~7.5, standing over night, fine straining, filtrate add the injection water; Make injection, powder pin, freeze-dried powder or infusion solution again.
3, preparation method according to the vermilion injection of claim 1 or 2 described treatment cardiovascular and cerebrovascular diseases is characterized in that: the freeze-dried powder in the described preparation is preparation like this: with the 3750g Radix Salviae Miltiorrhizae, the 1250g Flos Carthami decocts with water secondary, add 10 times of water gagings at every turn, each 1 hour, merge decoction liquor, filter, filtrate is concentrated into 5000ml, and the gelatin solution of adding 5% makes gelatine content be calculated as 1% by the quality percent by volume, stirs evenly, cold preservation is spent the night, filter, filtrate concentrates, and adds ethanol and makes and contain the alcohol amount more than 80%, cold preservation is spent the night, filter, filtrate is regulated pH value more than 7 with 10%NaOH, and cold preservation is spent the night, filter, filtrate recycling ethanol concentrates, and adds the injection dilute with water, add active carbon after boiling and be equivalent to 0.1% of crude drug amount, keep little and boiled 30 minutes, filter, filtrate is used 10%NaOH adjust pH 5.5~7.5, boil, standing over night, fine straining, filtrate adds the injection water; 667g mannitol is mixed with 20% solution,, filters with the filtrate mixing, packing, lyophilization, promptly.
4, preparation method according to the vermilion injection of claim 1 or 2 described treatment cardiovascular and cerebrovascular diseases is characterized in that: the powder injection formulation in the described preparation is preparation like this: with the 3750g Radix Salviae Miltiorrhizae, the 1250g Flos Carthami decocts with water secondary, add 10 times of water gagings at every turn, each 1 hour, merge decoction liquor, filter, filtrate is concentrated into 5000ml, and the gelatin solution of adding 5% makes gelatine content be calculated as 1% by the quality percent by volume, stir evenly, cold preservation is spent the night, and filters, filtrate concentrates, and adds ethanol and makes and contain the alcohol amount more than 80%, and cold preservation is spent the night, filter, filtrate is regulated pH value more than 7 with 10%NaOH, and cold preservation is spent the night, and filters, filtrate recycling ethanol, concentrate, add the injection dilute with water, add active carbon after boiling and be equivalent to 0.1% of crude drug amount, keeping little boiled 30 minutes, filter, filtrate is boiled with 10%NaOH adjust pH 5.5~7.5, standing over night, fine straining, filtrate add injection water, spray drying, packing, promptly.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100532184A CN100571719C (en) | 2004-02-20 | 2005-02-16 | The preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200410021884.5 | 2004-02-20 | ||
CN200410021884 | 2004-02-20 | ||
CNB2005100532184A CN100571719C (en) | 2004-02-20 | 2005-02-16 | The preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1817356A CN1817356A (en) | 2006-08-16 |
CN100571719C true CN100571719C (en) | 2009-12-23 |
Family
ID=36917684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100532184A Active CN100571719C (en) | 2004-02-20 | 2005-02-16 | The preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100571719C (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102233001B (en) * | 2010-05-06 | 2013-03-13 | 菏泽步长制药有限公司 | Chinese medicinal composition for treating cardiovascular and cerebrovascular diseases as well as preparation method and detection method thereof |
CN102145043A (en) * | 2011-04-18 | 2011-08-10 | 天圣制药集团股份有限公司 | Medicinal composition for treating cardiovascular diseases, and preparation and preparation method thereof |
CN108524632B (en) * | 2018-04-11 | 2020-11-06 | 哈尔滨市康隆药业有限责任公司 | Preparation process of concentrated oral liquid for treating infantile cough and asthma |
-
2005
- 2005-02-16 CN CNB2005100532184A patent/CN100571719C/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN1817356A (en) | 2006-08-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100453094C (en) | Medicine composition of effective parts for compound Tongmai Chinese medicine oral liquid and its preparing method | |
CN100571719C (en) | The preparation method of the vermilion injection of treatment cardiovascular and cerebrovascular disease | |
CN1923241B (en) | Medicine composition containing epimedium extract, uncaria extract, and gastrodine, and its preparation and use | |
CN103655791B (en) | A kind of lotus leaf-based preparation for treating phlegm and blood stasis simultaneously and application thereof | |
CN103893283B (en) | A kind of Chinese medicine composition for treating chronic kidney disease and chronic kidney hypofunction and preparation method thereof | |
CN101947247B (en) | Method for preparing ginkgodipyidamolum injection | |
CN1698717B (en) | Chinese medicinal compound fat emulsion injection and its preparation method | |
Koo et al. | Extraction of hypotensive principles from seeds of Cassia tora | |
CN104971088A (en) | Tibetan artemisia capillaris extract and preparation method, drug composition and application thereof | |
CN100431562C (en) | Chinese traditional medicinal preparation containing red sange root and safflower for treating cardiovascular and cerebrovascular diseases and preparing process thereof | |
CN102626427B (en) | Ginkgo dipyridamole composition and preparation method of preparation thereof | |
CN103655653A (en) | Application of macroporous weakly acidic rosin based cationic exchange resin to adsorption of toxic ingredients in panax notoginseng saponins | |
CN102988461B (en) | A kind of gadol injection and preparation method thereof | |
CN106361811B (en) | One kind is promoted blood circulation pharmaceutical composition and preparation method thereof | |
CN100540017C (en) | A kind of Chinese medicine preparation for the treatment of angina pectoris and preparation method thereof | |
CN100484929C (en) | Rod sage root extract and making method of its preparation | |
CN105380985B (en) | Pharmaceutical composition for treating cerebral arterial thrombosis | |
CN102988643B (en) | Traditional Chinese medicine injection for dispersing brain blood | |
CN1977898A (en) | Chinese medicine for treating cardio-cerebrovascular disease | |
CN1927346B (en) | Mailuoning injection and preparation thereof | |
CN1961911A (en) | Lyophilized powder injection containing red sage root and dalbergia wood volatile oil and preparation method thereof | |
CN100443095C (en) | Compound formulation of breviscapine and asarum herb for treating cardiovascular and cerebrovascular diseases and its application | |
CN1954862B (en) | Syrup for treating headache | |
CN101757129B (en) | Composition preparation containing orientin and isoorientin and preparation method thereof | |
CN102028749A (en) | Lyophilized powder injection for treating cardiovascular diseases and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170927 Address after: 274000 No. 99, Kunming Road, peony Industrial Park, Shandong, Heze Patentee after: SHANDONG DANHONG PHARMACEUTICAL CO., LTD. Address before: 100070 Beijing city Fengtai Science City boat No. 8 halfway life science and Technology Incubation Center (Jingfeng pharmaceutical factory hospital) room 511 Beijing Yide singular source Pharmaceutical Research Institute Patentee before: Yu Wenyong |